MoonLake posts Capital Markets Day presentation; no specific data disclosed in filing text

MoonLake Immunotherapeutics

Company filed a Form 8-K announcing the posting of an investor presentation for Capital Markets Day on June 7, 2022.
Presentation covers clinical development program and recent developments, but no concrete figures or updates are provided in the excerpt.
Full presentation is available on the company's IR website; no financial or pipeline details are included in the 8-K text.
This filing is procedural under Regulation FD; material content requires review of the actual presentation slides.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.